Stressors, stress, and neuroendocrine integration of the adaptive response the 1997 hans selye memorial lecture

Annals of the New York Academy of Sciences

Volumn 851, Issue , 1998, Pages 311-335

  Chrousos, George P ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ADRENAL MEDULLA; AMYGDALOID NUCLEUS; BEHAVIOR; CATECHOLAMINE NERVE CELL; CHOLINERGIC SYSTEM; CONFERENCE PAPER; FOOD INTAKE; GASTROINTESTINAL TRACT FUNCTION; GENITAL SYSTEM; GROWTH; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; INTEGRATION; LIMBIC CORTEX; NEUROENDOCRINE SYSTEM; PATHOPHYSIOLOGY; PHYSIOLOGY; STRESS; THERMOREGULATION; THYROID GLAND;

EID: 0031872236     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09006.x     Document Type: Article

References (53)

1. CHROUSOS, G. P., D. L. LORIAUX & P. W. GOLD. 1988. The concept of stress and its historical development. In Mechanisms of Physical and Emotional Stress. Plenum. New York. Adv. Exp. Med. Biol. 245: 3-7.
2. CHROUSOS, G. P. & P. W. GOLD. 1992. The concepts of stress and stress system disorders: Overview of physical and behavioral homeostasis. JAMA 267: 1244-1252.
3. TSIGOS, C. & G. P. CHROUSOS. 1995. Stress, endocrine manifestations and diseases. Chapter 3. In Handbook of Stress Medicine. C. L. Cooper, Ed.: 61-65. CRC Press. Boca Raton, FL.
4. LICINIO, J., C. MANTZOROS, A. B. NEGRAO, G. CIZZA, M. L. WONG, P. B. BONGIORNO, G. P. CHROUSOS, B. KARP, C. ELLEN, J. S. FLIER & P. W. GOLD. 1997. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat. Med. 3: 575-579.
5. CHROUSOS, G. P. 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332: 1351-1362.
6. CHROUSOS, G. P., S. DETERA-WADLEIGH & M. KARL. 1993. Syndromes of glucocorticoid resistance. Ann. Int. Med. 119: 1113-1124.
7. BAMBERGER, C. M., H. M. SCHULTE & G. P. CHROUSOS. 1996. Molecular determinants of glucocorticoid receptor function and tissue sensitivity. Endocrinol. Rev. 17: 221-244.
8. LUGER, A., P. DEUSTER, S. B. KYLE, W. T., GALLUCCI, L. C. MONTGOMERY, P. W. GOLD, D. L. LORIAUX & G. P. CHROUSOS. 1987. Acute hypothalamic-pituitary-adrenal responses to the stress and treadmill exercise physiologic adapatations to physical training. N. Engl. J. Med. 316: 1309-1315.
9. VAMVAKOPOULOS, N. C. & G. P. CHROUSOS. 1993. Evidence of direct estrogen regulation of human corticotropin releasing hormone gene expression: Potential implications for the sexual dimorphism of the stress response and immune/inflammatory reaction. J. Clin. Invest. 92: 1896-1902.
10. GALLUCCI, W. T., A. BAUM, L. LAUE, D. S. RABIN, G. P. CHROUSOS, P. W. GOLD & M. A. KLING. 1993. Sex differences in sensitivity of the hypothalamic-pituitary-adrenal axis. Health Psychol. 12: 420-425.
11. VAMVAKOPOULOS, N. C. & G. P. CHROUSOS. 1994. Hormonal regulation of human corticotropin releasing hormone gene expression: Implications for the stress response and immune/inflammatory reaction. Endocrinol. Rev. 15: 409-420.
12. CHROUSOS, G. P. 1997. The neuroendocrinology of stress: Its relation to the hormonal milieu, growth, and development. Growth Genet. & Horm. 13: 1-8.
13. FRIEDMAN, T. C., G. MASTORAKOS, T. D. NEWMAN, N. M. MULLEN, E. G. HORTON, R. COSTELLO, N. M. PAPADOPOULOS & G. P. CHROUSOS. 1996. Carbohydrate and lipid metabolism in endogenous hypercortisolism: Shared features with metabolic syndrome X and noninsulin-dependent diabetes mellitus. Endocr. J. 43: 645-656.
14. ROY, M. S., A. ROY, W. T. GALLUCCI, B. COLLIER, K. YOUNG, T. C. KAMILARIS & G. P. CHROUSOS. 1993. The ovine corticotropin releasing hormone test in type I diabetic patients and controls: Suggestion of mild chronic hypercortisolism. Metabolism 42: 696-700.
15. PAPANICOLAOU, D. A., R. L. WILDER, S. C. MANOLAGAS & CHROUSOS G. P. 1998. The pathophysiologic roles of interleukin-6 in humans. Ann. Intern. Med. 128: 127-137.
16. MASTORAKOS, G., G. P. CHROUSOS & J. WEBER. 1993. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J. Clin. Endocrinol. Metab. 27: 1690-1694.
17. TSIGOS, C., D. A. PAPANICOLAOU, R. DEFENSOR, C. S. MITSIADES, I. KYROU & G. P. CHROUSOS. 1997. Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 66: 54-62.
18. MASTORAKOS, G., J. S. WEBER, M. A. MAGIAKOU, H. GUNN & G. P. CHROUSOS. 1994. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: Potential implications for the syndrome of inappropriate vasopressin secretion. J. Clin. Endocrinol. Metab. 79: 1191-1197.
19. REINCKE, M., B. ALLOLIO, W. ARLT, C. HEPPNER, F. PETCKE, D. MBULAMBERI, L. SIEKMAN, D. VOLLMER, W. WINKLEMAN & G. P. CHROUSOS. 1994. Impairment of adrenocortical function associated with Increased plasma tumor necrosis factor-α and interleukin-6 concentrations in African trypanosomiasis. NeuroImmunoModulation 1: 14-22.
20. MICHELSON, D., L. STONE, E. GALLIVEN, M. A. MAGIAKOU, G. P. CHROUSOS, E. M. STERNBERG & P. W. GOLD. 1994. Multiple scelrosis is associated with alterations in hypothalamic-pituitary-adrenal function. J. Clin. Endocrinol. Metab. 79: 848-853.
21. BERNARDINI, R., A. CALOGERO, G. MAUCERI & G. P. CHROUSOS. 1990. Rat hypothalamic corticotropin releasing hormone secretion in vitro is stimulated by interleukin-1 in an eicosanoid-dependent manner. Life Sci. 47: 1601-1607.
22. BERNARDINI, R., A. CHIARENZA, A. E. CALOGERO, P. W. GOLD & G. P. Chrousos. 1989. Arachidonic acid metabolites modulate rat hypothalamic corticotropin releasing hormone secretion in vitro. Neuroendocrinology 50: 708-715.
23. LUGER, A., A. CALOGERO, K. KALOGERAS, W. GALLUCCI, P. W. GOLD, D. L. LORIAUX & G. P. CHROUSOS. 1987. Interaction of epidermal growth factor with the hypothalamicpituitary-adrenal axis: Potential physiologic relevance. J. Clin. Endocrinol. Metab. 66: 334-337.
24. BOUMPAS, D. T., G. P. CHROUSOS, R. L. WILDER, T. R. CUPPS & J. E. BALOW. 1993. Glucocorticoid therapy of immune-related diseases: Basic and clinical correlates. Ann. Inter. Med. 119: 1198-1208.
25. WEBSTER, E. L., I. J. ELENKOV & G. P. CHROUSOS. 1997. The role of corticotropin-releasing hormone in neuroendocrine-immune interactions. Mol. Psychiatry 2: 368-372.
26. THEOHARIDES, T. C., C. SPANOS, Z. PANG, L. ALFERES, K. LIGRIS, R. LETOURNEAU, J. J. ROZNIECKI, E. L. WEBSTER & G. P. CHROUSOS. 1995. Stress-induced intracranial mast cell degranulation: A corticotropin-releasing hormone-mediated effect. Endocrinology 136: 5745-5750.
27. ELENKOV, I. J., D. A. PAPANICOLAOU, R. L. WILDER & G. P. CHROUSOS. 1996. Modulatory effects of glucocorticoid and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications. Proc. Assn. Am. Phys. 108: 374-381.
28. CHROUSOS, G. P. 1997. The future of pediatric and adolescent endocrinology. Ann. N.Y. Acad. Sci. 816: 4-8.
29. GOLD, P. W., F. GOODWIN & G. P. CHROUSOS. 1988. Clinical and biochemical manifestations of depression: Relationship to the neurobiology of stress (Part I). N. Engl. J. Med. 319: 348-353.
30. GOLD, P. W., F. GOODWIN & G. P. CHROUSOS. 1988. Clinical and biochemical manifestations of depression: Relationship to the neurobiology of stress (Part II). N. Engl. J. Med. 319: 413-420.
31. GOLD, P. W., D. L. LORIAUX, A. ROY, M. A. LINK, J. R. CALABRESE, C. H. KELLNER, L. K. NIEMAN, R. M. POST, D. PICKAR, W. GALLUCCI, P. AVGERINOS, S. PAUL, E. H. OLDFIELD, G. B. CUTLER, JR. & G. P. CHROUSOS. 1986. Responses to corticotropin releasing hormone in the hypercortisolism of depression and Cushing's disease: Pathophysiologic and diagnostic implications. N. Engl. J. Med. 314: 1329-1335.
32. ROY, A., D. PICKAR, S. PAUL, A. DORAN & G. P. CHROUSOS. 1987. CSF corticotropin releasing hormone in depressed patients and normal control subjects. Am. J. Psychiatry 114: 641-645.
33. KLING, M. A., A. DORAN, D. R. RUBINOW, A. ROY, R. M. POST, G. P. CHROUSOS & P. W. GOLD. 1991. CSF levels of CRH, ACTH and SRIF in Cushing's syndrome, major depression, and normal volunteers: Physiological and pathophysiological interrelationships. J. Clin. Endocrinol. Metab. 72: 260-271.
34. RAADSHEER, F. C., W. J. HOODENDIJK, F. S. STAM, F. J. H. TILDERS & D. F. SWAAB. 1994. Increased numbers of corticotropin-releasing hormone expresing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60: 436-444.
35. SHELINE, Y. I., P. W. WANG, M. H. GADO, J. G. CSERNANSKY & M. W. VANNIER. 1996. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. USA 93: 3908-3913.
36. DREVETS, W. C., J. L. PRICE, J. R. SIMPSON, JR., R. D. TODD, T. REICH, M. VANNIER & M. E. RAICHLE. 1997. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386: 824-827.
37. MICHELSON, D., C. STRATAKIS, L. Y. HILL, J. REYNOLDS, E. GALLIVEN, G. P. CHROUSOS & P. W. GOLD. 1996. Bone mineral density is decreased in women with depression. N. Engl. J. Med. 335: 1176-1181.
38. YANOVSKI, J. A., G. B. CUTLER, JR., G. P. CHROUSOS & L. K. NIEMAN. 1993. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration: A new test to distinguish Cushing's syndrome from Pseudo-Cushings states. JAMA 269: 2232-2238.
39. YANOVSKJ, J. A., S. Z .YANOVSKI, P. W. GOLD & G. P. CHROUSOS. 1997. Differences in corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol before and after weight loss. J. Clin. Endocrinol. Metab. 82: 1874-1878.
40. PACAK, K., R. MCCARTY, M. PALKOVTTZ, G. CIZZA, I. J. KOPIN, D. GOLDSTEIN & G. P. CHROUSOS. 1995. Decreased central and peripheral catecholaminergic activation in obese Zucker rats. Endocrinology 136: 4360-4367.
41. SCARINCI, I. C., J. MCDONALD-HAILE, L. A. BRADLEY, J. E. RICHTER. 1994. Altered pain perception and psychosocial features among women with gastrointestinal disorders and history of abuse: A preliminary model. Am. J. Med. 97: 108-118.
42. DEBELLIS, M., G. P. CHROUSOS, L. DORN, L. BURKE, K. HELMERS, M. A. KLING, P. K. TRICKETT & F. W. 1994. Putnam. Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. J. Clin. Endocrinol. Metab. 78: 249-255.
43. MCCAULEY, J., D. E. KERN, K. KOLODNER, L. HILL, A. F. SCHROEDER, H. K. DECHANT, J. RYDEN, L. R. DEROGATIS & E. B. BASS. 1997. Clinical characteristics of women with a history of childhood abuse. JAMA 277: 1362-1368.
44. MAGIAKOU, M. A., G. MASTORAKOS, D. RABIN, A. N. MARGIORIS, B. DUBBERT, A. E. CALOGERO, C. TSIGOS, P. J. MUNSON & G. P. CHROUSOS. 1996. The maternal hypothalamic-pituitary-adrenal axis in third trimester human pregnancy. Clin. Endocrinol. 44: 419-428.
45. WEBSTER, E. L., D. B. LEWIS, D. J. TORPY, K. E. ZACHMAN, K. C. RICE & CHROUSOS GP. 1996. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: Suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137: 5747-5750.
46. VANDERPOOL, J., N. ROSENTHAL, G. P. CHROUSOS, T. WEHR, R. SKEWERER, S. KASPER & P. W. GOLD. 1991. Evidence for hypothalamic CRH deficiency in patients with seasonal affective disorder. J. Clin. Endocrinol Metab. 72: 1382-1387.
47. DEMITRACK, M., J. DALE, S. STRAUS, L. LAUE, S. LISTWAK, M. KRUESI, G. P. CHROUSOS & P. W. GOLD. 1991. Evidence of impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 73: 1224-1234.
48. CROFFORD, L. J., S. R. PILLEMER, K. T. KALOGERAS, J. M. CASH, D. MICHELSON, M. A. KLING, E. M. STERNBERG, P. W. GOLD, G. P. CHROUSOS & R. L. WILDER. 1994. Hypothalamic-pituitary-adrenal axis perturbation in patients with fibromyalgia. Arthritis and Rheumatism 37: 1583-1592.
49. DORN, L. D., E. S. BURGESS, B. DUBBERT, M. KLING, P. W. GOLD & G. P. CHROUSOS. 1995. Psychopathology in patients with endogenous Cushing's syndrome: "Atypical" or "melancholic" features. Clin. Endocrinol. 43: 433-442.
50. DORN, L. D., E. S. BURGESS, T. C. FRIEDMAN, B. DUBBERT, P. W. GOLD & G. P. CHROUSOS. 1997. The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. J. Clin. Endocrinol. Metab. 82: 912-919.
51. MAGIAKOU, M. A., G. MASTORAKOS, D. RABIN, B. DUBBERT, P. W. GOLD & G. P. CHROUSOS. 1996. Hypothalamic corticotropin releasing hormone suppression during the postpartum period: Implications for the increase of psychiatric manifestations during this time. J. Clin. Endocrinol. Metab. 81: 1912-1917.
52. CHIKANZA, I. C., P. PETROU, G. P. CHROUSOS, G. KINGSLEY & G. PANAYI. 1992. Detective hypothalamic response to immune/inflammatory stimuli in patients with rheumatoid arthritis. Arthritis and Rheum. 35: 1282-1288.
53. CROFFORD, L. J., K. T. KALOGERAS, G. MASTORAKOS, M. A. MAGIAKOU, J. WELLS, K. S. KANIK, P. W. GOLD, G. P. CHROUSOS & R. L. WILDER. 1997. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J. Clin. Endocrinol. Metab. 82: 1279-1283.